ImmunoPrecise Antibodies Ltd. (HYFT)
Market Open
15 Jun, 15:50
NASDAQ (NMS) NASDAQ (NMS) Primary $
1. 64
+0.07
+4.8077%
$
78.48M Market Cap
- P/E Ratio
- Div Yield
137,879 Volume
- Eps
$ 1.56
Previous Close Analysts:
Want to track HYFT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
ImmunoPrecise Antibodies Ltd. (HYFT) Statistics
Valuation metrics
Market Cap 78.48M
Enterprise value 91.29M
Trailing P/E (ttm) -8.33
Forward P/E -
PEG ratio -0.05
Price/Sales (ttm) 5.55
Price/Book (mrq) 6.78
Enterprise Value/Revenue 4.97
Enterprise Value/EBITDA -8.62
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 275.28K
Average volume (90 days) 295.55K
Price summary
52-Week low 0.7
52-Week high 3.25
Beta -
50-Day moving average 1.46
200-Day moving average 1.55
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:5
Last split Date 23 Nov 2020
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.66%
Operating margin -0.65%
Operational effectiveness
Return on assets -0.53%
Return on equity -0.63%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.39
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.26
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.3
Total debt (mrq) -
Total Debt/Equity (mrq) 0.24
Current ratio (mrq) 3.74%
Book value per share (mrq) 0.32
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
